AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Auctimet G 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Bioaltus Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Auctimet G 1mg/500mg Tablet SR

Diabetic patients treated with the anti-diabetic medication, Auctimet G 1mg/500mg SR tablets, a dual-action formulation, manage their type 2 diabetes mellitus more effectively. This combination therapy regulates blood glucose in adults. Administer this medication with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continuous use, even with controlled blood sugar, is crucial. Discontinuing treatment without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this drug is only one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular exercise, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and have a readily available quick-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. Contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Auctimet G 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Auctimet G 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Auctimet G 1mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this extended-release tablet with a meal.

Common Side effects of Auctimet G 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Auctimet G 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Auctimet G 1mg/500mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this extended-release tablet with food.

How Auctimet G 1mg/500mg Tablet SR works:

Auctimet G SR tablets (1mg glimepiride/500mg metformin) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar. Metformin, a biguanide, acts through a triple mechanism: decreasing hepatic glucose output, inhibiting intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Auctimet G 1mg/500mg SR tablets with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Auctimet G 1mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Auctimet G 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Auctimet G 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Auctimet G 1mg/500mg SR tablets. Physician consultation is necessary. Kidney function should be regularly monitored during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Auctimet G 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate liver disease; the medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Auctimet G 1mg/500mg Tablet SR :

Should you forget a dose of Auctimet G 1mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Auctimet G 1mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Diabetes medication

FAQs on Auctimet G 1mg/500mg Tablet SR

Always keep this medication in its original, tightly sealed container. Follow the storage instructions provided on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Auctimet G 1mg/500mg Tablet SR can induce lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those consuming significant quantities of alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Auctimet G 1mg/500mg Tablet SR and seek immediate medical attention.
Auctimet G, a sustained-release tablet containing 1mg glimepiride and 500mg metformin, manages type 2 diabetes mellitus in adults. This dual-agent therapy enhances glycemic control when coupled with a balanced diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion to reduce blood glucose, while metformin decreases hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Auctimet G 1mg/500mg Extended-Release Tablets may cause common adverse reactions including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Serious, though infrequent, side effects such as lactic acidosis are also possible. Prolonged therapy may result in vitamin B12 deficiency.
Prolonged use of Auctimet G 1mg/500mg SR tablets can lead to Vitamin B12 deficiency due to impaired absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive strategies proposed by some studies include supplemental Vitamin B12 intake at least annually.
Auctimet G 1mg/500mg SR tablets can induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. These symptoms are exacerbated by missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Auctimet G 1mg/500mg SR tablets and alcohol is unsafe. Alcohol consumption with this medication can reduce blood glucose, potentially causing hypoglycemia, and heighten the risk of lactic acidosis.
Auctimet G 1mg/500mg Tabl...
45
MRP 55
18% off